Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 6/2009

01.12.2009 | ORIGINAL ARTICLE

Remarkable differences: the course of life of young adults with galactosaemia and PKU

verfasst von: A. M. Bosch, H. Maurice-Stam, F. A. Wijburg, M. A. Grootenhuis

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Summary

Although the need for insight in factors influencing the quality of life of patients with an inborn error of metabolism is recognized, psychological adjustment of adults with metabolic diseases has not been properly studied. Adult patients with PKU were demonstrated not to differ from healthy controls in terms of their course of life (CoL) and health-related quality of life (HRQoL). However, adults with galactosaemia had a lower HRQoL with significant lower scores on the domains of cognitive and social function. This study investigated the CoL and the social demographical outcomes in these young adults with galactosaemia, and compared them with the general population and with PKU patients. A total of 15 (88%) adult patients with classical galactosaemia participated in this study. Classical galactosaemia patients had a delayed social and psychosexual development compared to their peers from the general population and to PKU patients. Also, they were significantly less frequently married or living together and significantly less frequently employed than the general population. Our study shows a stark contrast between patients with galactosaemia and patients with PKU, although both are diagnosed in the neonatal period and need life-long dietary restrictions. The observed difference is likely due to the long-term somatic complications frequently seen in galactosaemia and thus not due to the burden of a chronic disease necessitating life-long dietary restrictions. We conclude that it is essential that parents and clinicians encourage children with galactosaemia to participate in peer-related activities in order to stimulate social performance, which may result in a more normal CoL.
Literatur
Zurück zum Zitat Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HSA, Wijburg FA, Last BF (2004) Living with classical galactosemia, health related quality of life consequences. Pediatrics 113(5):e423–428CrossRefPubMed Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HSA, Wijburg FA, Last BF (2004) Living with classical galactosemia, health related quality of life consequences. Pediatrics 113(5):e423–428CrossRefPubMed
Zurück zum Zitat Bosch AM, Ijlst L, Oostheim W et al (2005) Identification of novel mutations in classical galactosemia. Hum Mutat 25(5):502CrossRefPubMed Bosch AM, Ijlst L, Oostheim W et al (2005) Identification of novel mutations in classical galactosemia. Hum Mutat 25(5):502CrossRefPubMed
Zurück zum Zitat Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30(1):29–34CrossRefPubMed Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30(1):29–34CrossRefPubMed
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioral sciences. New York: Academy Press Cohen J (1988) Statistical power analysis for the behavioral sciences. New York: Academy Press
Zurück zum Zitat Garber J (1984) Classification of childhood psychopathology: a developmental perspective. Child Dev 55:30–48CrossRefPubMed Garber J (1984) Classification of childhood psychopathology: a developmental perspective. Child Dev 55:30–48CrossRefPubMed
Zurück zum Zitat Gassio R, Artuch R, Vilaseca MA et al (2005) Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a pediatric population. Dev Med Child Neurol 47:443–448CrossRefPubMed Gassio R, Artuch R, Vilaseca MA et al (2005) Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a pediatric population. Dev Med Child Neurol 47:443–448CrossRefPubMed
Zurück zum Zitat Grootenhuis MA, Stam H, Destrée-Vonk A, Heijmans HSA, Last BF (2003) Levensloop Vragenlijst voor Jong-Volwassenen. [Course of life questionnaire for young adults]. Gedrag Gezond 31:336–350 Grootenhuis MA, Stam H, Destrée-Vonk A, Heijmans HSA, Last BF (2003) Levensloop Vragenlijst voor Jong-Volwassenen. [Course of life questionnaire for young adults]. Gedrag Gezond 31:336–350
Zurück zum Zitat Lambert C, Boneh A (2004) The impact of galactosemia on quality of life—a pilot study. J Inherit Metab Dis 27(5):601–608CrossRefPubMed Lambert C, Boneh A (2004) The impact of galactosemia on quality of life—a pilot study. J Inherit Metab Dis 27(5):601–608CrossRefPubMed
Zurück zum Zitat Last BF, Grootenhuis MA, Destrée-Vonk A, Heymans HSA (2000) De ontwikkeling van een levensloopvragenlijst voor jong-volwassenen (LVJV). [The development of a course of life questionnaire for young adults]. Gedrag Gezond 8:22–30 Last BF, Grootenhuis MA, Destrée-Vonk A, Heymans HSA (2000) De ontwikkeling van een levensloopvragenlijst voor jong-volwassenen (LVJV). [The development of a course of life questionnaire for young adults]. Gedrag Gezond 8:22–30
Zurück zum Zitat Lewis M, Miller SM (1990) Handbook of developmental psychopathology. New York: Plenum PressCrossRef Lewis M, Miller SM (1990) Handbook of developmental psychopathology. New York: Plenum PressCrossRef
Zurück zum Zitat Lundstedt G, Johansson A, Melin L, Alm J (2001) Adjustment and intelligence among children with phenylketonuria in Sweden. Acta Paediatr 90:1147–1152CrossRefPubMed Lundstedt G, Johansson A, Melin L, Alm J (2001) Adjustment and intelligence among children with phenylketonuria in Sweden. Acta Paediatr 90:1147–1152CrossRefPubMed
Zurück zum Zitat Schweitzer S, Shin Y, Jacobs C, Brodehl J (1993) Long-term outcome in 134 patients with galactosemia. Eur J Paediatr 152:36–43CrossRef Schweitzer S, Shin Y, Jacobs C, Brodehl J (1993) Long-term outcome in 134 patients with galactosemia. Eur J Paediatr 152:36–43CrossRef
Zurück zum Zitat Stam H, Grootenhuis MA, Last BF (2005). The course of life of survivors of childhood cancer. Psychooncology 14:227–238CrossRefPubMed Stam H, Grootenhuis MA, Last BF (2005). The course of life of survivors of childhood cancer. Psychooncology 14:227–238CrossRefPubMed
Zurück zum Zitat Waggoner DD, Buist NRM, Donnell GN (1990) Long-term prognosis in galactosemia: Results of a survey of 350 cases. J Inherit Metab Dis 13:802–818CrossRefPubMed Waggoner DD, Buist NRM, Donnell GN (1990) Long-term prognosis in galactosemia: Results of a survey of 350 cases. J Inherit Metab Dis 13:802–818CrossRefPubMed
Zurück zum Zitat Weglage J, Funders B, Wilken B et al (1992) Psychosocial and social findings in adolescents with phenylketonuria. Eur J Paediatr 151:522–525CrossRef Weglage J, Funders B, Wilken B et al (1992) Psychosocial and social findings in adolescents with phenylketonuria. Eur J Paediatr 151:522–525CrossRef
Metadaten
Titel
Remarkable differences: the course of life of young adults with galactosaemia and PKU
verfasst von
A. M. Bosch
H. Maurice-Stam
F. A. Wijburg
M. A. Grootenhuis
Publikationsdatum
01.12.2009
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 6/2009
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1253-2

Weitere Artikel der Ausgabe 6/2009

Journal of Inherited Metabolic Disease 6/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.